ProCE Banner Activity

Shifting the Treatment Paradigm of Weight Management and Type 2 Diabetes in Primary Care

Slideset

Leading experts in diabetes discuss the evidence and guidelines around appropriate incretin-based therapy for obesity and type 2 diabetes, from Clinical Education Alliance (CEA).

Released: November 03, 2023

Share

Faculty

Martin J. Abrahamson

Martin J. Abrahamson, MD, FACP

Associate Professor of Medicine
Harvard Medical School
Director, Division of CME
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Amy Butts

Amy Butts, PA-C, MPAS, DFAAPA, CDCES, BC-ADM

Physician Assistant
Department of Endocrinology
WVU Medicine Wheeling Hospital
Wellsburg, West Virginia

Debbie Hinnen

Debbie Hinnen, APN, BC-ADM, CDCES, FAAN

Certified Diabetes Care and Education Specialist
Consultant, University of Colorado Health
Colorado Springs, Colorado

Provided by

Provided by Partners for Advancing Clinical Education (PACE) and Clinical Care Options, LLC (CCO).

ProCE Banner
ProCE Banner

Supporters

Supported by educational grants from Lilly and GlaxoSmithKline.

GlaxoSmithKline

Lilly